World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
21594
World Ranking
3771
National Ranking
1728

Douglas C. Palmer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Douglas C. Palmer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 93 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Douglas C. Palmer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas C. Palmer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Douglas C. Palmer is affiliated with the National Institutes of Health in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, and Cancer Research.

The scientist's work centers on topics such as Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, CRISPR and Genetic Engineering, Immune cells in cancer, and T-cell and B-cell Immunology.

Recent publications include the following papers:

  • STING agonist promotes CAR T cell trafficking and persistence in breast cancer, 2020, The Journal of Experimental Medicine
  • Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies, 2020, Cancer Cell
  • Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade, 2022, Med
  • A T cell resilience model associated with response to immunotherapy in multiple tumor types, 2022, Nature Medicine
  • Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade, 2020, bioRxiv (Cold Spring Harbor Laboratory)

The scientist has frequently published in venues such as Regular and Young Investigator Award Abstracts, bioRxiv (Cold Spring Harbor Laboratory), Nature Medicine, Cancer Research, and SSRN Electronic Journal.

Prominent collaborators include Rigel J. Kishton, Scott A. Hammond, Nicholas P. Restifo, Devikala Gurusamy, and Suman K. Vodnala. These coauthors have worked with Douglas C. Palmer on multiple occasions, reflecting recurring collaborative efforts.

Best Publications

  • Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

    Luca Gattinoni;Steven E. Finkelstein;Christopher A. Klebanoff;Christopher A. Klebanoff;Paul A. Antony

  • Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

    Christopher A. Klebanoff;Luca Gattinoni;Parizad Torabi-Parizi;Keith Kerstann

  • Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

    Luca Gattinoni;Christopher A. Klebanoff;Christopher A. Klebanoff;Douglas C. Palmer;Claudia Wrzesinski

  • Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells

    Willem W. Overwijk;Marc R. Theoret;Steven E. Finkelstein;Deborah R. Surman

  • Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells

    Luca Gattinoni;Xiao-Song Zhong;Douglas C Palmer;Yun Ji

  • Tumor-specific Th17-polarized cells eradicate large established melanoma

    Pawel Muranski;Andrea Boni;Paul A. Antony;Lydie Cassard

  • Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function

    Madhusudhanan Sukumar;Jie Liu;Yun Ji;Murugan Subramanian

  • CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4 T helper cells and hindered by naturally occurring T regulatory cells.

    Paul A. Antony;Ciriaco A. Piccirillo;Akgül Akpinarli;Steven E. Finkelstein

  • IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells

    Christopher A. Klebanoff;Steven E. Finkelstein;Deborah R. Surman;Michael K. Lichtman;Michael K. Lichtman

  • Ionic immune suppression within the tumour microenvironment limits T cell effector function

    Robert Eil;Suman K. Vodnala;David Clever;Christopher A. Klebanoff;Christopher A. Klebanoff

  • Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8 + T cells via TLR4 signaling

    Chrystal M. Paulos;Claudia Wrzesinski;Andrew Kaiser;Christian S. Hinrichs

  • Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy

    Christopher A. Klebanoff;Hung T. Khong;Paul A. Antony;Douglas C. Palmer

  • IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.

    Christian S. Hinrichs;Rosanne Spolski;Chrystal M. Paulos;Luca Gattinoni

  • T cell stemness and dysfunction in tumors are triggered by a common mechanism.

    Suman Kumar Vodnala;Robert Eil;Rigel J. Kishton;Madhusudhanan Sukumar

  • Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature

    Pawel Muranski;Zachary A. Borman;Sid P. Kerkar;Christopher A. Klebanoff

  • Adoptively transferred effector cells derived from naïve rather than central memory CD8+ T cells mediate superior antitumor immunity

    Christian S. Hinrichs;Zachary A. Borman;Lydie Cassard;Luca Gattinoni

  • Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy

    Madhusudhanan Sukumar;Jie Liu;Gautam U. Mehta;Shashank J. Patel

  • Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics

    Joseph G. Crompton;Joseph G. Crompton;Joseph G. Crompton;Madhusudhanan Sukumar;Rahul Roychoudhuri;David Clever;David Clever

  • Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy

    Christian S. Hinrichs;Zachary A. Borman;Luca Gattinoni;Zhiya Yu

  • High-Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation

    Yangbing Zhao;Zhili Zheng;Cyrille J. Cohen;Luca Gattinoni

  • MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer

    Jan C. Dudda;Bruno Salaun;Yun Ji;Douglas C. Palmer

Frequent Co-Authors

Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
Luca Gattinoni
Luca Gattinoni University of Regensburg
Christopher A. Klebanoff
Christopher A. Klebanoff Memorial Sloan Kettering Cancer Center
Zhiya Yu
Zhiya Yu National Institutes of Health
Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Chrystal M. Paulos
Chrystal M. Paulos Emory University
Richard A. Morgan
Richard A. Morgan University of California, Los Angeles
Chi-Chao Chan
Chi-Chao Chan National Institutes of Health
Warren J. Leonard
Warren J. Leonard National Institutes of Health
Lawrence E. Samelson
Lawrence E. Samelson National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields such as nursing can open diverse career opportunities. Many students pursue nursing degrees online, seeking flexibility without compromising quality. Programs labeled as the easiest nurse practitioner program can offer a streamlined pathway into advanced nursing roles by focusing on core competencies with efficient curricula.

Mental health is another critical area tied to Immunology studies, especially regarding neuro-immune interactions. Prospective students may consider pmhnp programs online with best clinical placement to ensure hands-on experience is incorporated into their education, a vital step towards licensure and practical expertise.

Cost is a significant factor for many learners. Finding the cheapest psychiatric nurse practitioner programs can make specialized healthcare education more accessible without sacrificing quality. These programs help prepare graduates for high-demand roles in psychiatric care.

Finally, understanding the financial outlook is crucial. Careers such as Doctor of Nursing Practice (DNP) holders often enjoy competitive salaries, which can vary by location. Reviewing the dnp salary data by state provides valuable insight into expected earnings and job market conditions.

Best Scientists Citing Douglas C. Palmer

Trending Scientists

Recently Published Articles